Steven R. Ph.D. Gullans's Net Worth
$823 Thousand
Who is Steven R. Ph.D. Gullans?
Steven R. Ph.D. Gullans does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, Gemphire Therapeutics Inc., AILERON THERAPEUTICS INC, and iSpecimen Inc..
SEC CIK
Steven R. Ph.D. Gullans's CIK is 0001571997
Past Insider Trading and Trends
2018 was Steven R. Ph.D. Gullans's most active year for acquiring shares with 4 total transactions. Steven R. Ph.D. Gullans's most active month to acquire stocks was the month of December. 2014 saw Steven R. Ph.D. Gullans paying a total of $230,977.50 for 35,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRAPHASE PHARMACEUTICALS INC No price found
InvestorSteven R. Ph.D. Gullans owns 25,000 units of Common Stock. In the year 2013 Steven R. Ph.D. Gullans filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
∞
| 25K |
$9.24 | $230,977.50 | 25K |
May 19
| |||
Form 4
|
∞
| 1.47M |
$7.00 |
—
| 1.47M |
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gemphire Therapeutics Inc. (NRBO) Snapshot price: $3.51
President & CEOSteven R. Ph.D. Gullans owns 300,000 units of Common Stock which is worth $1,053,000.00. In the year 2016 Steven R. Ph.D. Gullans filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
|
∞
| 300K |
—
|
—
| 300K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
| +8.32% | 71.43K |
$7.00 | $500,003.00 | 930.25K |
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 30
| |||
Form 4
| +6.55% | 52.8K |
$9.47 | $499,997.06 | 858.82K |
Mar 10
| |||
Form 4
|
∞
| 806.02K |
$8.75 | $7,052,173.05 | 806.02K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AILERON THERAPEUTICS INC (ALRN) Snapshot price: $2.6
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.02M |
$15.00 |
—
| 1.02M |
Jul 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iSpecimen Inc. (ISPC) Snapshot price: $0.254
InvestorSteven R. Ph.D. Gullans owns 3,250 units of Common Stock which is worth $825.50. From 2021 to 2024 Steven R. Ph.D. Gullans acquired a total of 125 shares in iSpecimen Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +4.00% | 125 |
—
|
—
| 3.25K |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||